INTRODUCTION
In recent years, many potential genetic mechanisms have been proposed to participate in human brain speciation. These include changes in transcriptional regulation (Enard et al., 2002; Konopka et al., 2009) , accelerated evolution of small noncoding RNAs (Pollard et al., 2006) , changes in the activity and/or region-specificity of enhancer elements (McLean et al., 2011; Prabhakar et al., 2006 Prabhakar et al., , 2008 or changes in patterns of alternative splicing (Calarco et al., 2007) . So far, very few studies have assessed the functional consequences of these changes. Another important mechanism is genomic duplication, which generates copies of genetic material that serve as substrates for molecular evolution (Hurles, 2004; Ohno, 1970) . In fact, recent lines of evidence have revealed that a burst of large segmental gene duplications occurred in the human lineage during its separation from nonhuman primates approximately 6 million years ago (Bailey et al., 2002; Fortna et al., 2004) . Several of the genes contained in these duplications are expressed in the developing brain. This has led to the hypothesis that these evolutionarily recent gene duplications might have participated in the emergence of human-specific features of brain development and function (Bailey and Eichler, 2006; Sikela, 2006; Stankiewicz and Lupski, 2010; Varki et al., 2008) . However, this hypothesis has never been tested experimentally. The principal obstacles have been that the function of the ancestral genes is often unknown and that the duplications are poorly assembled in the current human genome because of their high degree of conservation with the ancestral gene.
In this study, we focused on SLIT-ROBO Rho-GTPaseactivating protein 2 (SRGAP2), a gene highly expressed during brain development (Bacon et al., 2009; Guerrier et al., 2009) . The protein SRGAP2 is composed of three functional domains (Guerrier et al., 2009) : an N-terminal F-BAR (Bin, Amphiphysin, Rvs) domain (Itoh et al., 2005) involved in membrane deformation, a central Rho GTPase-Activating Protein (Rho-GAP) domain that specifically stimulates the GTPase activity of Rac1, and a C-terminal tail containing an SH3 domain. We previously demonstrated that SRGAP2 controls cortical neuron migration (Guerrier et al., 2009) . Recent analysis of large segmental duplications has revealed that SRGAP2 has two main duplicates in the Homo neanderthalensis and Homo sapiens genomes, but not in the genome of our closest living relatives, the chimpanzee, orangutan and gorilla (Sudmant et al., 2010) . In this study, we mapped the location and genomic structure of the human-specific SRGAP2 paralogs (see also accompanying article by Dennis et al. [2012] in this issue of Cell). We provide evidence that they are expressed in human neurons and encode a truncated F-BAR domain that interacts with ancestral SRGAP2 to inhibit its function. We used in vitro and in vivo approaches to determine the function of SRGAP2 and its human paralogs in the neocortex region of the brain, the evolution of which is thought to underlie the emergence of human cognitive abilities. Our results uncover a new function for ancestral SRGAP2 in promoting dendritic spine maturation and indicate that expression of a human-specific paralog of SRGAP2 in mouse pyramidal neurons extends the phase of spine development and leads to an increased density of longer spines in vivo, a feature characterizing pyramidal neurons in the human neocortex (Benavides-Piccione et al., 2002; Elston et al., 2001) .
RESULTS

Genomic Organization of SRGAP2 Paralogs
The gene SRGAP2 was identified by using array comparative genomic hybridization (aCGH) as having undergone humanspecific duplication, resulting in extra copies in the H. sapiens genome, but not in the genomes of four nonhuman primates (Fortna et al., 2004) . However, the number and locations of these human-specific copies were unknown. Using the Blast-Like Alignment Tool (BLAT), we searched the GRCh36/hg18 reference genome (available human genome assembly in 2006 at the start of the project) with the cDNA of human SRGAP2 (GenBank BC132874.1). We located the ancestral SRGAP2 gene at chromosome 1q32.1 (SRGAP2A) and two duplicates at 1q21.1 and 1p12 (hereafter referred to as SRGAP2B and SRGAP2C, respectively) that showed more than 99% similarity to the query sequence (Figures S1A and 1B available online). The observation that there are two duplicates of SRGAP2 in the human genome was recently confirmed and validated by analysis of copy number variation in whole-genome shotgun sequencing data (Sudmant et al., 2010) . Even in the most recent reference assembly (GRCh37/hg19), the ancestral SRGAP2A gene is classified as misassembled, and SRGAP2B and SRGAP2C lie in recently duplicated regions of the genome that are incompletely assembled and present large contig gaps. In order to determine the approximate genomic organization of these three paralogs, we retrieved human bacterial artificial chromosome (BAC) clones mapping to these three loci. To fill in the gaps in the assembled sequence, we performed BLAST searches against the end sequences database by using genome sequences flanking the gaps as inputs. The exon organization of the human BACs was determined by dot blot hybridization with several probes covering different portions of the entire extent of SRGAP2 cDNA (data not shown). In addition, exons in each BAC clone were sequenced from the human BAC DNA either directly before or following amplification to reveal the organization of the three SRGAP2 paralogs (data not shown, Figure S1C ). The full sequencing and assembly of the three genomic loci and their recent evolution is the focus of the accompanying paper by Dennis et al. (2012) . Both analyses revealed that SRGAP2A contains 22 exons and encodes a protein with 1,071 amino acids (aa), which is 98% identical to its mouse ortholog SRGAP2, whereas SRGAP2B and SRGAP2C have a 3 0 breakpoint located in intron 9 of the ancestral copy and are predicted to express a protein containing 459 aa. The first 452 aa correspond to the first 452 aa of the F-BAR domain of SRGAP2A (aa1-501; Guerrier et al., 2009) . Because intron 9 of SRGAP2A becomes 3 0 untranslated region (3 0 untranslated region [UTR]) in SRGAP2B and SRGAP2C, both use an alternate stop codon located in intron 9, which adds 7 aa (VRECYGF; Figure 1A ). We identified two potential polyadenylation sites in the 3 0 UTRs of SRGAP2B and SRGAP2C based on the clustering of expressed sequence tags (EST) from the database of Expressed Sequence Tags (dbEST). The two 3 0 UTRs are $1.4 kb or 5 kb long. Taken together, our results indicate that both paralogs encode a truncated F-BAR domain that lacks the last C-terminal 49 aa.
Expression of SRGAP2 Paralogs
We isolated one cDNA clone from a human library (GenBank BC112927.1) originating from SRGAP2C that is almost identical in sequence to the first 9 exons of the ancestral SRGAP2A, except for five nonsynonymous base pair mutations (out of 1,356 base pairs) mutating five arginine (5R) residues ( Figure 1A ). As shown in the accompanying paper by Dennis et al. (2012) , SRGAP2B and SRGAP2C are identical apart from a few base pair mutations, and both lack the last 49 aa of the F-BAR domain. In order to determine the expression of these human-specific paralogs in the brain, we took advantage of the fact that intron 9 becomes 3 0 UTR in SRGAP2B and SRGAP2C to perform in situ hybridization (ISH) on cryostat sections from human fetal cortex (gestational week [GW] 11). SRGAP2B and SRGAP2C were therefore detected using an intron 9 probe that does not recognize processed mRNA encoding ancestral SRGAP2A, whereas SRGAP2A was detected using an exon 22 probe that conversely does not recognize SRGAP2B or SRGAP2C (Figures 1A and 1B and data not shown) . This analysis revealed a striking similarity in the pattern of expression of the paralogs in the germinal layers (ventricular zone [VZ] and subventricular zone [SVZ] ), in which neural progenitors divide to produce postmitotic neurons. We also detected significant expression in the cortical plate ( Figure 1B) , in which neurons end their migration and undergo terminal differentiation and synapse formation. To refine this gene expression analysis, we took advantage of the possibility to differentiate human embryonic stem cells (hESCs) into relatively pure populations of forebrain excitatory pyramidal neurons (Kim et al., 2011) . Total RNA was harvested from hESCs at different time points during their directed differentiation in vitro (Kim et al., 2011) , allowing us to perform a temporal analysis using reverse-transcriptase PCR (RT-PCR) primers ( Figure 1C and Table S1 ), amplifying SRGAP2A (exon 10-11 junction) or SRGAP2B and SRGAP2C (intron 9) transcripts. Both ancestral and human-specific paralogs of SRGAP2 were detected at low levels in undifferentiated hESCs that express OCT4 (lane 1 in Figure 1C ). Their expression increased in a mixture of neural progenitor cells (PAX6+) and immature neurons (TUJ1) (3 weeks in culture [wic], Kim et al., 2011 ; lane 2 in Figure 1C ) as well as in more mature, synaptically active, PSD95-expressing Figure S1 and Table S1 .
hESC-derived neurons (5 wic; Kim et al., 2011; lane 3 in Figure 1C) . Both transcripts were also detected using RT-PCR from unpooled mRNA isolated from an individual human fetal brain (GW16; lane 4 in Figure 1C ) and from the brain of a 44-year-old adult human (lane 5 in Figure 1C ). In order to compare the relative level of expression of transcripts encoded by the paralogs and to tease apart transcripts derived from SRGAP2B and SRGAP2C, we took advantage of a fixed single base pair variation in exon 6 of SRGAP2C to design a set of primers specifically amplifying SRGAP2C transcripts (but not chimpanzee or human SRGAP2A transcripts or human SRGAP2B transcripts; Table S1 and Figure 1D ). Quantitative-RT-PCR (qRT-PCR) revealed that both SRGAP2C and SRGAP2A transcripts were abundant in hESC-derived neurons that were cultured for 3 and 5 weeks, compared to undifferentiated hESCs ( Figure 1E ). However, SRGAP2C transcript maintained a higher level of expression than SRGAP2A after 5 wic ( Figure 1E ). This suggests that SRGAP2C and SRGAP2A transcripts do not systematically covary and might be under different regulatory mechanisms, leading to different transcript abundance in human neurons.
We next wanted to determine whether a protein product corresponding to the translation of SRGAP2B or SRGAP2C transcripts could be detected in human cells. In transfected HEK293T cells, which do not express endogenous SRGAP2, SRGAP2A could be detected in a western blot using an antibody directed against either the C-terminal (aa873-890) or the N-terminal (aa193-205) domain of the protein ( Figure 1F , gray arrow). As predicted, SRGAP2C was detected as a single band of a lower molecular weight only by using the antibody directed against the N-terminal of SRGAP2 ( Figure 1F , red arrow). In the human SH-SY5Y neuroblastoma cell line and the human MCF7 breast cancer cell line, a 120 kDa protein corresponding to SRGAP2A ( Figure 1G , grey arrow) and a 50 kDa protein (red arrow) were detected with the N-terminal SRGAP2 antibody. The 50 kDa product was not detected in the same lysates by using the C-terminal SRGAP2 antibody, in lysates isolated from postnatal day (P) 7 mouse cortex, or from the mouse fibroblast NIH3T3 cell line, suggesting that it originates from human-specific SRGAP2B or SRGAP2C ( Figure 1G ). We confirmed that the 50 kDa protein product detected with the N-terminal SRGAP2 antibody in neuroblastoma SH-SY5Y cells was specifically translated from SRGAP2B or SRGAP2C by using two independent small interfering RNAs (siRNAs; called siRNA intron9-1 and intron9-2) targeting intron 9, i.e., the 3 0 UTR of the endogenous SRGAP2B and SRGAP2C mRNA that is absent in endogenous SRGAP2A mRNA (lanes 2 and 3 in Figure 1H ). The 50 kDa protein product was detected in human SH-SY5Y cells transfected with control scramble siRNA, but not in cells transfected with siRNA intron9-1 or intron9-2 (Figure 1H ). Overall, our results demonstrate that SRGAP2A and its human-specific paralog SRGAP2C are expressed in fetal and adult human brains and neurons.
SRGAP2C Interacts with and Inhibits Ancestral SRGAP2
In Vitro Next, we explored the potential function of the human-specific paralogs of SRGAP2. Because the F-BAR domain is a homodimerization domain involved in membrane deformation , and because SRGAP2C encodes most of the F-BAR domain of the ancestral SRGAP2A protein, we tested whether it retained the ability to dimerize with full-length SRGAP2. In HEK293T cells, hemagglutinin (HA)-tagged SRGAP2C was coexpressed with either SRGAP2A-GFP or SRGAP2C-enhanced green fluorescent protein (EGFP), followed by HA immunoprecipitation. Our results showed that SRGAP2C protein can dimerize with both SRGAP2A and SRGAP2C (Figure 2A) . This suggests that the few aa substitutions in the sequence of SRGAP2C, as well as the deletion of the last 49 aa, do not alter the ability of SRGAP2C to dimerize with fulllength SRGAP2A. In order to explore the biological function of SRGAP2C protein, we employed a robust membrane deformation assay in COS7 cells (Guerrier et al., 2009) . As previously shown for mouse SRGAP2 (Guerrier et al., 2009) , expression of human SRGAP2A-EGFP induced filopodia protrusions in COS7 cells (Figures 2B, 2C, and 2L) . In contrast, expression of SRGAP2C-monomeric red fluorescent protein (mRFP) failed to induce filopodia ( Figures 2D and 2L) . Furthermore, when coexpressed with ancestral SRGAP2A-EGFP, SRGAP2C-mRFP efficiently blocked its ability to induce filopodia ( Figures 2E and 2L) . Expressing a cDNA encoding SRGAP2B (clone provided by Megan Dennis from E. Eichler's laboratory) gave similar results ( Figures 2F, 2G , and 2L). Two features of SRGAP2C might account for this ability to block SRGAP2A function: (1) the mutation of several arginine residues that could mediate membrane binding/deformation properties (Shimada et al., 2007) and (2) the truncation of the F-BAR domain by deleting the last 49 aa (see Figure 1A) . To test the relative contribution of these two duplicate-specific differences, we introduced these mutations individually into the native F-BAR domain of ancestral SRGAP2 (F-BAR-D5R and F-BAR-D49, respectively). Although both mutations abolished the filopodia induction properties of the F-BAR domain ( Figures 2H, 2J , and 2L), only F-BAR-D49 mimicked SRGAP2C with regard to its ability to antagonize SRGAP2-mediated membrane protrusions (Figures 2K and 2L) . Combined with the observation that the deletion of the most C-terminal 49 aa, but not the 5R mutations, is a common feature of SRGAP2C and SRGAP2B, our data suggest that both human-specific paralogs can interact with ancestral SRGAP2A and inhibit its function.
SRGAP2C Inhibits SRGAP2 Function during Cortical Neuron Migration
We then decided to test whether the human-specific duplicates of SRGAP2 can also inhibit the documented function of SRGAP2 during cortical neuron migration (Guerrier et al., 2009 ). We focused on SRGAP2C for further experiments because in the human brain, SRGAP2C transcripts are substantially more abundant than SRGAP2B transcripts (see accompanying paper by Dennis et al. [2012] ). We used in utero electroporation to compare the in vivo function of SRGAP2 and its human-specific paralog, SRGAP2C. Mouse cortical progenitors generating layer 2/3 pyramidal neurons were electroporated at E14.5 and analyzed at E18.5, which is when most control neurons have exited the cell cycle, engaged radial migration, and a significant portion have reached their final position in the cortical plate (CP).
As previously demonstrated for mouse SRGAP2 in ex vivo electroporated slices of embryonic cortices (Guerrier et al., 2009) , overexpression of human ancestral SRGAP2A induced excessive branching of the leading process (LP) of radially migrating neurons compared to control ( Figures 3A and 3B) , resulting in slower migration with less neurons accumulating in the CP after 4 days in utero ( Figures 3C and 3D) . Conversely, knockdown of SRGAP2 by using a short hairpin RNA (shRNA) ( Figure S2 ) resulted in a reduction of LP branches on migrating neurons as compared to neurons expressing control shRNA (Figures 3A and 3B) , and this reduction has been shown to increase the rate of migration (Guerrier et al., 2009) . Interestingly, neurons expressing SRGAP2C showed a reduction in LP branching that was very similar to that seen after SRGAP2 knockdown ( Figures 3A and 3B) , which results in an increased rate of radial migration as quantified by the proportion of neurons successfully reaching the CP after 4 days in utero ( Figures 3C and 3D ). These results support the notion that the function of ancestral SRGAP2 is conserved between mouse and human and is inhibited by SRGAP2C expression in vivo. compared to control ( Figure S3 ). Indeed, although SRGAP2C expression was found to accelerate neuronal migration, this is not expected to alter cell positioning in the context of insideout cortical neuron migration. The absence of an overt effect on neuronal placement allowed us to address the potential function of SRGAP2 at later stages of brain development. We and others have recently shown that SRGAP2 is highly expressed in the mouse neocortex during the first weeks after birth (Bacon et al., 2009; Guerrier et al., 2009 ), a period critical for spinogenesis and synaptogenesis in rodents (Miller, 1986; Romand et al., 2011) . Therefore, we decided to investigate the currently unknown function of SRGAP2 in dendritic spines. In the neocortex, spines receive most of the excitatory connections and are a critical site of structural and functional synaptic plasticity (Holtmaat and Svoboda, 2009; Yuste and Bonhoeffer, 2001) . In mouse cortical neurons cultured for 20 days in vitro (DIV), endogenous SRGAP2 showed a punctate staining that was apposed to the presynaptic marker SYNAPSIN1 and extensively colocalized with the postsynaptic marker HOMER1 (Figure 4A ), indicating that SRGAP2 is enriched at excitatory synapses. Overexpression of mRFP-tagged SRGAP2 with EGFP-tagged HOMER1c showed that SRGAP2 strongly accumulates in the head of dendritic spines with HOMER1 clusters ( Figure 4B ). Subcellular fractionation further confirmed that SRGAP2 is associated with synaptic membranes and is detected in the postsynaptic density ( Figure S4 ). We next performed several loss-and gain-of-function experiments and measured key parameters of spine morphology: (1) the width of the spine head, which correlates with the size of the postsynaptic density, the number of synaptic AMPA glutamate receptors, and the number of presynaptic vesicles (Arellano et al., 2007; Bourne and Harris, 2007; Harris and Stevens, 1989; Matsuzaki et al., 2004 ) and can be used as an indicator of spine maturation (Harris and Stevens, 1989) and (2) the length of the spine neck, which impacts the biochemical and potentially the electrical isolation of the spine head from the dendritic shaft (Araya et al., 2006; Noguchi et al., 2005; Yuste, 2011) . We first studied SRGAP2 function in cultured cortical neurons by using RNA interference (see Figure S2 ). Plasmids expressing a control shRNA or shRNA against mouse Srgap2 (shSrgap2) were introduced into neurons using magnetofection after 11 DIV, and spine morphology was quantified 9 to 10 days later. Neurons expressing a control shRNA ( Figure 4C ) exhibited spines with an average spine head width of 0.458 ± 0.004 mm (n = 1,377) ( Figure 4D ) and an average neck length of 0.56 ± 0.01 mm ( Figure 4E ). shSrgap2-expressing neurons displayed immature-looking spines (Figure 4C ) with smaller head width (0.367 ± 0.004 mm, n = 1,139, Figure 4D ) and longer spine neck (87 ± 0.02 mm, Figure 4E ) than control shRNA-expressing neurons. We also observed an increase in spine density from 1.25 ± 0.04 spine.mm À1 in control neurons (n = 15) to 2.14 ± 0.13 spine.mm À1 in shSrgap2-expressing neurons (n = 15). The effects of SRGAP2 knockdown on spine morphology and density could be rescued by coexpressing the shRNA against Srgap2 with an shRNA-resistant cDNA ( Figures  S2 and 4C -4E, density after rescue: 1.20 ± 0.06 spine.mm À1 , Figure S5 and Table S2 . n = 15). Conversely, in gain-of-function experiments, overexpression of SRGAP2 for only 48 hr induced a striking enlargement of dendritic spines in 20 DIV neurons, as visualized by cotransfection with EGFP ( Figure 4F ). Upon SRGAP2 overexpression, most spines were mushroom shaped, with larger spine heads ( Figure 4G ) and shorter spine necks (Figure 4H ) than spines in control neurons. Interestingly, SRGAP2 was barely detected in long, thin spines but was strongly accumulated in spines with large heads (see arrowheads in Figure 4B ). Altogether, these results suggest that SRGAP2 is a new postsynaptic protein that promotes spine head enlargement.
SRGAP2 Promotes Spine Maturation and Limits Spine Density in the Neocortex
To obtain further insights into the function of SRGAP2 in vivo, we took advantage of a gene trap allele of Srgap2, hereafter called Srgap2 KO (SRGAP2 Gt(XH102)Byg/Mmcd , available at MMRRC-UC Davis, Figures S5A-5C ). Mapping of the insertion site in intron 2 by using an inverse PCR strategy allowed us to design a PCR genotyping protocol to distinguish the heterozygous mice from the homozygous mice ( Figures S5A-5C ). The homozygous Srgap2 KO mice showed an $90% reduction in the level of Srgap2 transcript ( Figure S5D ), as well as protein ( Figures 5A-5B ) in the cortex, whereas heterozygous mice expressed intermediate levels of Srgap2 mRNA and protein. Srgap2 KO mice were viable (although born significantly below the expected Mendelian ratio; see Table S2 ) and showed no abnormality in cortical lamination ( Figures S6A and 6B ). Srgap2 KO mice were crossed with reporter mice expressing yellow fluorescent protein (YFP) in layer 5 pyramidal neurons (Thy1-YFP line H; Feng et al., 2000) , allowing quantitative assessment of dendritic spine morphology ( Figure S6C ). In juvenile mice (P18-P21), analysis of spines in apical oblique dendrites (see arrows in Figure S6C ) of layer 5 pyramidal neurons from wild-type, heterozygous, and homozygous KO mice ( Figure 5C ) revealed that SRGAP2 deficiency decreased the width of spine heads ( Figure 5D ) and increased the length of spine necks ( Figure 5E ), which is consistent with the results obtained with cultured neurons. These morphological defects were associated with a marked increase in the density of dendritic spines ( Figure 5F ). Interestingly, these changes were dose dependent. Indeed, in juvenile mice heterozygous for Srgap2, spines were thinner, longer, and more numerous than in wild-type mice, but to a lesser extent than in KO mice ( Figures 5C-5F ). We then wondered whether these defects were transient or maintained in adults. In adults (>P65 mice) (Figure 5G ), the size of spine heads in wild-type mice was in the same range as in wild-type juveniles ( Figures 5D and 5H) , indicating that spines were already morphologically mature at P21. This is consistent with a previous report on the development of layer 5 pyramidal neurons (Romand et al., 2011) . In contrast, heterozygous and KO neurons showed a substantial growth of their spine heads between juvenile and adult stages (Figures 5D and 5H ). We observed a 22% and a 40% increase in the mean head width in heterozygous and KO neurons, respectively, so that the size of spine heads in these neurons was close to the value measured in wild-type neurons ( Figure 5H ) and even slightly larger (8% and 10% larger in heterozygous and KO neurons, respectively, and see Figure S6D ). These data strongly suggest that SRGAP2-deficient neurons were still immature at P21 but eventually reached maturation in adults. Importantly, adult SRGAP2-deficient neurons maintained spines with longer necks and a spine density $1.4-fold higher than in wild-type neurons ( Figures 5I and 5J ). Taken together, these results indicate that (1) SRGAP2 promotes spine maturation and limits spine density in vivo and (2) SRGAP2 coregulates spine density with the length of spine neck. Thus, at low SRGAP2 levels, the phase of spinogenesis is extended, and adult neurons display more numerous spines with longer necks, which may have a profound impact on neuronal connectivity and synaptic input integration.
Expression of Human-Specific SRGAP2C in Mouse Neurons Delays Spine Maturation and Increases Spine Number Based on all the results shown so far, we hypothesized that longterm expression of the human protein SRGAP2C would delay spine maturation. In vitro, mouse cortical neurons that were maintained for 20 DIV and analyzed 2 days posttransfection of SRGAP2C displayed significant changes in spine morphology ( Figures 6A-6C ). These changes were opposite to the overexpression of SRGAP2 (see Figures 4F-4H ) and similar to the shRNA-mediated knockdown of SRGAP2 (see Figures 4C-4E) . We next analyzed in juvenile mice the consequences of SRGAP2C expression in layer 2/3 pyramidal neurons following in utero electroporation at E15.5. The coexpression of myristoylated Venus allowed the visualization of neuronal morphology ( Figure 6D ). As expected, in juvenile mice, SRGAP2C-expressing neurons exhibited numerous immature-looking spines as compared to control neurons ( Figure 6E ). Spines in SRGAP2C-expressing neurons had smaller head ( Figure 6F ), longer neck ( Figure 6G ), and were present at a higher density ( Figure 6H ) than in control neurons. In adult SRGAP2C-expressing neurons ( Figure 6I ), spine head widths were similar to control neurons (Figure 6J ), but both spine neck length ( Figure 6K ) and spine density ( Figure 6L ) remained significantly higher than in control neurons. Again, these effects were highly similar to what we observed in SRGAP2-deficient layer 5 pyramidal neurons in vivo ( Figures  5C-5J) . Overall, these results show that expression of SRGAP2C in the mouse neocortex leads to changes in spine development that are compatible with an inhibition of endogenous SRGAP2 and result in neoteny during dendritic spine maturation.
DISCUSSION
Inhibition of SRGAP2 Function Leads to Sustained Radial Migration
Our study is among the first to address the functional consequence of human-specific gene duplication during brain development. We show that the human-specific paralogs of SRGAP2, along with the ancestral copy, are expressed in developing and adult neurons at the RNA and protein levels. The SRGAP2 duplicates encode a truncated F-BAR domain that binds to and antagonizes the function of ancestral SRGAP2 during neuronal migration and morphogenesis. We previously showed that, in the mouse fetal brain, SRGAP2 is upregulated at the end of cortical migration, at which point it promotes branching in the leading process and decreases the rate of migration (Guerrier et al., 2009) . Here, we found that introduction of human-specific SRGAP2C in utero in mouse pyramidal neurons mimics SRGAP2 deficiency during neuronal migration, leading to a deficit in branching in the leading process of migrating neurons and allowing neurons to reach their final position in the cortical plate faster than control neurons. We propose that these effects of human-specific SRGAP2C expression may underlie a more persistent form of radial migration and delay its termination. This could support the journey of neurons over the total thickness of the cortical wall, which is substantially increased in humans as compared to nonhuman primates or rodents (Dehay and Kennedy, 2007; Rakic, 2009; Sidman and Rakic, 1973) .
Temporal Control of Spine Development
Numerous proteins have been implicated in the formation, maturation, and maintenance of spines (Bourne and Harris, 2008; Dillon and Goda, 2005; Elias et al., 2008; Hayashi et al., 2009) , but the mechanisms regulating the timing of spine development in vivo remain poorly understood. In this study, we demonstrate that SRGAP2 associates with the postsynaptic density to promote spine maturation and limits spine density in vivo. In contrast, SRGAP2 deficiency or expression of SRGAP2C delays spine maturation and leads to an increased density of spines with longer necks in the neocortex. These results suggest that SRGAP2C-induced neoteny extends the period of spine production with longterm consequences on their morphology. This altered developmental trajectory of spine maturation may reflect changes in excitatory synaptic development. Other genes have been shown to produce heterochrony during organ development with critical consequences for limb morphogenesis (Dollé et al., 1993) or for the expansion of the neocortical surface (Lui et al., 2011; Rakic, 2009) , supporting the notion that slower developmental processes might underlie increasingly complex morphogenesis.
Studies that have quantitatively compared spine morphology, spine density, and the developmental time course of spinogenesis between human and monkey or mouse have revealed that (1) spinogenesis in prefrontal areas presents neoteny in humans (Huttenlocher and Dabholkar, 1997; Petanjek et al., 2011) ; (2) spine density in comparable neocortical areas and layers is higher in humans (Benavides-Piccione et al., Elston et al., 2001); and (3) there are substantial differences in spine morphology between species, as human spines have longer necks and larger heads than in the other species analyzed (Benavides-Piccione et al., 2002) . Our results suggest that the human-specific duplication of SRGAP2 is involved in the emergence of these differences. In the human brain, the rate of spine development differs between cortical areas (Huttenlocher and Dabholkar, 1997) . Further investigations will test whether expression of SRGAP2C shows spatial heterogeneity.
Functional Implications of Human-Specific SRGAP2 Duplication Spines are known to enhance synaptic connectivity, enable linear integration of synaptic inputs, and implement synapsespecific plasticity (Yuste, 2011) . The spine neck represents a physical barrier between the synaptic contact in the spine head and the dendritic shaft. The length of the neck impacts the compartmentalization of synaptic signaling and the filtering of synaptic inputs, whereas the volume of the spine head is an indicator of the size of the postsynaptic density and the strength of the synapse (Bourne and Harris, 2008; Yuste, 2011) . Both the neck and the head of spines undergo morphological and functional plasticity (Bloodgood and Sabatini, 2005; Matsuzaki et al., 2004; Yuste and Bonhoeffer, 2001) , and spines with a larger head and a wider, shorter neck have been observed after induction of synaptic potentiation in rodents (Yuste and Bonhoeffer, 2001) . We found that SRGAP2 coregulates the density of spines and the length of the spine neck. Accordingly, SRGAP2-deficient neurons or SRGAP2C-expressing neurons harbored spines with longer necks and higher spine density. In our experiments, spine heads in adult SRGAP2-deficient neurons were comparable in size to wild-type neurons. In this context, we speculate that expression of SRGAP2C might allow human cortical pyramidal neurons to receive and integrate a significantly higher number of synaptic inputs without saturation. Such morphological features have been proposed to introduce more opportunities and more flexibility for input integration and information processing in human cortical circuits (Benavides-Piccione et al., 2002) . On the other hand, expression of SRGAP2 might also contribute to the higher susceptibility to neurodegenerative or psychiatric disorders of the human brain (Konopka et al., 2009) .
Taken together, our results suggest that the expression of SRGAP2C in the human brain inhibits the function of ancestral SRGAP2 and thereby reduces the rate of spine maturation, leading to changes in spine morphology and density that could have important implications for cognition, learning, and memory. SRGAP2 is both a membrane-binding protein and a Rho-GAP for the small GTPase Rac1, which has been associated with neurodevelopmental disorders (Govek et al., 2005) . It will be important to address the molecular mechanisms by which SRGAP2 promotes spine maturation and to address how SRGAP2C interferes with this process. A large genomic alteration affecting the human ancestral SRGAP2A gene has recently been reported in a patient with early-infantile encephalopathy with associated epilepsy (Saitsu et al., 2011) . However, this study was based on a single patient presenting a large chromosomal translocation that affected the expression of SRGAP2A, as well as other genes. Future investigations will test whether alterations in copy number or sequence variation of ancestral SRGAP2A or its human-specific paralogs underlie neurodevelopmental or cognitive defects, such as autism spectrum disorders or schizophrenia.
EXPERIMENTAL PROCEDURES Constructs
Human SRGAP2A (GenBank BC132874) and SRGAP2C (GenBank BC112927) cDNA were obtained from the IMAGE consortium. cDNA encoding SRGAP2B was a gift from the Eichler laboratory. See Extended Experimental Procedures for details of constructs used in this paper.
RNA In Situ Hybridization
The human fetal material (GW11) used to perform in situ hybridization was collected and used according to the guidelines of the three relevant local ethics committees on research involving human subjects (Erasme Academic Hospital, University of Brussels, and Belgian National Fund for Scientific Research). Written informed consent was given by the parents in each case. Exon 22 of SRGAP2A (3316-4271 base pairs [bp] of BC132874) and intron 9 (1992-3128 bp of BC112927) were amplified and cloned into pGEM-T Easy Vector System 1 (Promega), and they served as templates for generating RNA in situ probes. In situ hybridization on human embryonic brain samples was performed as previously described (Lambert et al., 2011) .
Animals
All animals were handled according to protocols approved by the institutional animal care and use committee (IACUC) at the University of North Carolina at Chapel Hill and The Scripps Research Institute, La Jolla. For timed pregnant matings, noon after mating is considered embryonic day 0.5 (E0.5). Juveniles correspond to mice between postnatal day (P) 18 and P21, and adults correspond to mice between P65 and P77. For information regarding genetic strains, refer to Extended Experimental Procedures.
In Utero Electroporation
We performed in utero electroporation as per a previously described protocol (Yi et al., 2010) . Endotoxin-free plasmid DNA was injected at a concentration of 1 mg/ml in the lateral ventricles. In case of coelectroporation, we injected equimolar quantities of the two plasmids to ensure coexpression. Please see Extended Experimental Procedures for electroporation settings, tissue preparation, slicing, and immunostaining of electroporated brains.
Primary Neuronal Culture, Magnetofection, and Immunocytochemistry Primary cultures of cortical neurons were prepared from embryonic BALB/c mice at days 17.5-18.5 and transfection was performed by magnetofection using NeuroMag (OZ Bioscience) according to the manufacturer's protocol at the indicated times. See details in Extended Experimental Procedures.
Morphometric Analysis of Spines
Morphometric analyses of dendritic spines were performed on z-projections for cultured neurons and in the depth of the z stack for slices using NISElements (Nikon imaging software). Head width was defined as the largest length of the head that was perpendicular to the neck. Neck length was measured from the point of attachment of the dendrite to the beginning of the spine head, as estimated by the investigator. When the neck could not be distinguished from the head, the neck length was considered to be zero. When the neck was not clearly visible, it was considered to be the shortest distance between the base of the head and the closest surface of the dendrite. Only spines arising from the lateral surfaces of the dendrites were taken into account. For analyses in slices, spines were quantified in the proximal part of oblique dendrites directly originating from the apical trunk. Spines were quantified over an average of 60 mm of dendrite in juvenile mice and 40 mm in adult mice. Spine density was defined as the number of quantified spines divided by the length over which the spines were quantified. The length of the dendritic segment was measured on the z projection, which implies that the density could be overestimated. To limit this issue, only dendrites that were parallel to the plane of the slice were analyzed. Spine analysis in vivo was analyzed in brain sections of comparable rostro-caudal position. See Extended Experimental Procedures for more details.
Subcellular Fractionation
Subcellular fractionation was performed from P15 mouse brains as described in Pé rez-Otañ o et al. (2006) 
